Drugs / polyclonal anti-D immunoglobulin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00952575 Comparator | Aug 2009 → Jul 2011 | — | LFB | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | polyclonal anti-D immunoglobulin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00952575 ↗ |
| Action | Deplete | “efficacy (in terms of Clearance of RhD-positive RBCs) and Safety of LFB-R593, a Monoclonal Anti-RhD Antibody vs a Polyclonal Anti-RhD Immunoglobulin” NCT00952575 ↗ |